Early statin therapy in patients with AMIEstimates of the rate of the primary endpoints

Ki Hong Lee et al, J Am Coll cardiol 2011;58:1664-71

Primary Endpoints: Composite of death,

recurrent MI and coronary revascularization

MACE adverse events:PCI

No. at risk 1,054 894 780 680

Statin therapygroup

607 529 457 400

Non-statin therapy group

447 365 323 280

Months after PCI

Cu

mu

lativ

e in

cid

en

ce o

f M

AC

E